Showing results (1031-1040 of 1,096) with videos related to
Sort By:
Pageof 110
British Journal of Haematology|July 30, 2016
Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiableDaniel J Landsburg, Marissa K Falkiewicz, Adam M Petrich, et al.The American Journal of Pathology|June 20, 2017
AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell LymphomaJinfen Wang, Zijun Y Xu-Monette, Kausar J Jabbar, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 14, 2021
Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology GroupRashmi Kanagal-Shamanna, Attilio Orazi, Robert P Hasserjian, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 25, 2019
Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinomaRoberto Ruiz-Cordero, Priya Rao, Lerong Li, et al.Science Immunology|August 8, 2017
Maintenance of macrophage transcriptional programs and intestinal homeostasis by epigenetic reader SP140Stuti Mehta, D Alexander Cronkite, Megha Basavappa, et al.Leukemia & Lymphoma|May 10, 2017
Radiation therapy improves survival in patients with testicular diffuse large B-cell lymphomaJennifer C Ho, Bouthaina S Dabaja, Sarah A Milgrom, et al.Leukemia|March 12, 2026
Immunophenotypic changes following menin inhibition in acute myeloid leukemiaSanam Loghavi, Aziz Farhat, Trevor J Jamison, et al.Journal of Medicinal Chemistry|April 29, 2026
Discovery of Casdatifan, Part I: Design and Characterization of Tetrahydroquinoline Inhibitors of Hypoxia-Inducible Factor-2αGuillaume Mata, Artur K Mailyan, Samuel L Drew, et al.Clinical Lymphoma, Myeloma & Leukemia|January 23, 2016
Doxorubicin-Based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution ReviewChelsea C Pinnix, Jatin J Shah, Hubert Chuang, et al.Journal of Medicinal Chemistry|July 3, 2020
Discovery of AB680: A Potent and Selective Inhibitor of CD73Kenneth V Lawson, Jaroslaw Kalisiak, Erick A Lindsey, et al.Pageof 110